Indoco Remedies Future Growth
Future criteria checks 4/6
Indoco Remedies is forecast to grow earnings and revenue by 72.2% and 11.7% per annum respectively. EPS is expected to grow by 70.7% per annum. Return on equity is forecast to be 12.1% in 3 years.
Key information
72.2%
Earnings growth rate
70.7%
EPS growth rate
| Pharmaceuticals earnings growth | 17.9% |
| Revenue growth rate | 11.7% |
| Future return on equity | 12.1% |
| Analyst coverage | Low |
| Last updated | 26 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 23,285 | 1,799 | 1,379 | 2,654 | 3 |
| 3/31/2026 | 20,523 | 1,239 | 470 | 2,102 | 5 |
| 3/31/2025 | 17,509 | 247 | -796 | 2,212 | 4 |
| 9/30/2024 | 17,732 | 321 | -3,076 | 2,220 | N/A |
| 6/30/2024 | 18,223 | 767 | N/A | N/A | N/A |
| 3/31/2024 | 18,173 | 985 | -2,706 | 1,567 | N/A |
| 12/31/2023 | 17,958 | 1,016 | N/A | N/A | N/A |
| 9/30/2023 | 17,356 | 1,134 | -911 | 1,442 | N/A |
| 6/30/2023 | 16,869 | 1,281 | N/A | N/A | N/A |
| 3/31/2023 | 16,686 | 1,423 | -284 | 1,788 | N/A |
| 12/31/2022 | 16,496 | 1,569 | N/A | N/A | N/A |
| 9/30/2022 | 16,084 | 1,617 | 85 | 1,703 | N/A |
| 6/30/2022 | 15,622 | 1,537 | N/A | N/A | N/A |
| 3/31/2022 | 15,408 | 1,548 | 485 | 1,738 | N/A |
| 12/31/2021 | 14,368 | 1,393 | N/A | N/A | N/A |
| 9/30/2021 | 14,110 | 1,317 | 257 | 1,391 | N/A |
| 6/30/2021 | 13,524 | 1,157 | N/A | N/A | N/A |
| 3/31/2021 | 12,415 | 930 | 54 | 822 | N/A |
| 12/31/2020 | 12,084 | 734 | N/A | N/A | N/A |
| 9/30/2020 | 11,654 | 571 | 387 | 931 | N/A |
| 6/30/2020 | 11,298 | 393 | N/A | N/A | N/A |
| 3/31/2020 | 11,066 | 241 | 644 | 1,228 | N/A |
| 12/31/2019 | 10,909 | 302 | N/A | N/A | N/A |
| 9/30/2019 | 10,640 | 264 | N/A | N/A | N/A |
| 6/30/2019 | 10,071 | 111 | N/A | N/A | N/A |
| 3/31/2019 | 9,684 | -29 | 352 | 1,321 | N/A |
| 3/31/2018 | 10,424 | 412 | N/A | 1,227 | N/A |
| 3/31/2017 | 10,968 | 771 | N/A | 886 | N/A |
| 3/31/2016 | 10,081 | 819 | N/A | 1,122 | N/A |
| 3/31/2015 | 8,570 | 828 | N/A | 1,090 | N/A |
| 3/31/2014 | 7,336 | 580 | N/A | 988 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 532612's forecast earnings growth (72.2% per year) is above the savings rate (6.7%).
Earnings vs Market: 532612's earnings (72.2% per year) are forecast to grow faster than the Indian market (17.9% per year).
High Growth Earnings: 532612's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 532612's revenue (11.7% per year) is forecast to grow faster than the Indian market (10.4% per year).
High Growth Revenue: 532612's revenue (11.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 532612's Return on Equity is forecast to be low in 3 years time (12.1%).